1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. IntelliPharmaCeutics Acquires Vasogen

M&A Deal Summary

IntelliPharmaCeutics Acquires Vasogen

On October 22, 2009, IntelliPharmaCeutics acquired life science company Vasogen

Acquisition Highlights
  • This is IntelliPharmaCeutics’ 1st transaction in the Life Science sector.
  • This is IntelliPharmaCeutics’ 1st transaction in Canada.
  • This is IntelliPharmaCeutics’ 1st transaction in Ontario.

M&A Deal Summary
Date 2009-10-22
Target Vasogen
Sector Life Science
Buyer(s) IntelliPharmaCeutics
Deal Type Add-on Acquisition

Target

Vasogen

Mississauga, Ontario, Canada
Vasogen, Inc. is a biotechnology company focused on destructive inflammatory processes associated with the development and progression of cardiovascular and neuro-inflammatory disorders.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

IntelliPharmaCeutics

Toronto, Ontario, Canada
Category Company
Founded 1998
Sector Healthcare Services
Employees11
Revenue 1M USD (2020)
DESCRIPTION

IntelliPharmaCeutics is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. IntelliPharmaCeutics was founded in 1998 and is based in Toronto, Ontario.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2009 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal